Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr;35(4):e246-e247.
doi: 10.1111/jdv.17052. Epub 2020 Dec 23.

Pityriasis rosea as a leading manifestation of COVID-19 infection

Affiliations
Case Reports

Pityriasis rosea as a leading manifestation of COVID-19 infection

R Merhy et al. J Eur Acad Dermatol Venereol. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Merhy, Dr Sarkis and Dr Stephan have nothing to disclose.

Figures

Figure. 1
Figure. 1
(a) Erythematous and scaly papules over the trunk, and (b) typical herald patch with the peripheral scaling collaret.

References

    1. Matar S, Oulès B, Sohier P et al. Cutaneous manifestations in SARS‐CoV‐2 infection (COVID‐19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol 2020; 34: e686–e689. - PMC - PubMed
    1. Freeman EE, McMahon DE, Lipoff JB et al. The spectrum of COVID‐19‐associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol 2020; 83: 1118–1129. - PMC - PubMed
    1. Martín Enguix D, Salazar Nievas MDC, Martín Romero DT. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID‐19. Med Clin Engl Ed 2020; 155: 273. - PMC - PubMed
    1. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID‐19 infection. J Eur Acad Dermatol Venereol 2020; 34: e436–e437. - PMC - PubMed
    1. Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19. J Med Virol 2021; 93: 1850–1851. - PMC - PubMed